News

The company said that the Phase 3 X-PECT (Xeloda + Perifosine Evaluation in Colorectal cancer Treatment) trial will be a randomised (1:1), double-blind trial comparing the efficacy and

Algeta’s lead product Alpharadin (based on radium-223) is a highly targeted alpha-pharmaceutical under clinical evaluation, to improve survival in patients with bone metastases from advanced cancer. Its localized

The goal of the collaboration is the energy-efficient and thus sustainable fermentative production of steroid compounds, using optimised microbial production strains taking plant derived raw materials as starting

The company said that once the review is completed, they intend to move forward a fully-compliant 510(k) submission. The submission will be based on the regulatory strategy and

The company claims that Juvederm is the first and only hyaluronic acid dermal filler approved by the FDA to last up to one year from initial treatment. Juvederm

COP (Cyclic Olefin Polymer) is a heavy-metal-free plastic that Gerresheimer has also used for sterile syringes over many years. It has specific advantages which makes it particularly suitable

The company claims that Tjet uses a needle-free delivery system that releases the same amount of Tev-Tropin as a traditional syringe in two seconds. Tjet works by releasing

The purpose of this study was to establish preliminary conditions for long-term stability of RiVax with the intent of avoiding the cold chain, usually required for storage of

The study looked at older patients with a median age of 70. These are patients who have had ‘no truly adequate treatments,’ however the study found that half